Sponsor
Nicholas A. Langworthy
Representative · R-NY
Representative · R-NY
The bill standardizes dietary supplement rules nationally—making labeling and compliance simpler for consumers and manufacturers—while trading away state and local authority and risking weaker local protections and slower relief where stronger rules were previously in place.
Consumers nationwide (including children and youth) get uniform federal standards for dietary supplements, reducing confusion about labeling and improving baseline safety expectations.
Manufacturers, including small businesses, gain regulatory uniformity that lowers compliance costs and simplifies interstate distribution of dietary supplements.
State and local governments lose authority to impose stricter safety or labeling rules tailored to local risks, limiting local policymaking flexibility.
Consumers in jurisdictions that currently have stronger protections could face weaker rules if the federal standard is less stringent, reducing local health protections.
The exemption process gives substantial discretion to the Secretary and may produce delays or barriers to local protections because of required rulemaking and hearing timelines.
Based on analysis of 2 sections of legislative text.
Creates a federal presumption that federal dietary supplement rules preempt differing state/local rules but allows the Secretary to grant narrow exemptions via regulation.
Creates a federal rule that generally prevents states and localities from imposing requirements on dietary supplements that differ from federal law, while giving the Secretary of Health authority to grant limited exemptions after public notice, comment, and a hearing. The exemption can apply if a state rule is more stringent than federal law or addresses a compelling local condition so long as it will not render the supplement noncompliant with federal requirements. The bill adds a new subsection to the Food, Drug, and Cosmetic Act establishing a presumption of federal preemption for dietary-supplement rules but builds a regulatory pathway for states or localities to seek narrow, case-by-case exceptions under standards set by the Secretary.
Official title: To amend the Federal Food, Drug, and Cosmetic Act to clarify and affirm the preemptive authority of the Food and Drug Administration over dietary supplement regulation, and for other purposes.
Introduced February 4, 2026 by Nicholas A. Langworthy · Last progress February 4, 2026